Eiger BioPharmaceuticals, Inc. - stock earnings
EIGR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -18.0 million USD | 3.2 million USD |
| 2023Q2 | -20.7 million USD | 4.6 million USD |
| 2023Q1 | -22.8 million USD | 4.1 million USD |
| 2022Q4 | -25.1 million USD | 2.7 million USD |
| 2022Q3 | -27.9 million USD | 4.0 million USD |
| 2022Q2 | -21.9 million USD | 4.1 million USD |
| 2022Q1 | -22.6 million USD | 2.7 million USD |
| 2021Q4 | -21.8 million USD | 3.4 million USD |
| 2021Q3 | -22.2 million USD | 3.0 million USD |
| 2021Q2 | -19.2 million USD | 2.1 million USD |
| 2021Q1 | 29.2 million USD | 3.6 million USD |
| 2020Q4 | -18.8 million USD | ? USD |
| 2020Q3 | -15.7 million USD | ? USD |
| 2020Q2 | -15.3 million USD | ? USD |
| 2020Q1 | -15.2 million USD | ? USD |
| 2019Q4 | -16.9 million USD | ? USD |
| 2019Q3 | -18.6 million USD | ? USD |
| 2019Q2 | -17.5 million USD | ? USD |
| 2019Q1 | -17.2 million USD | ? USD |
| 2018Q4 | -16.5 million USD | ? USD |
| 2018Q3 | -17.1 million USD | ? USD |
| 2018Q2 | -9.9 million USD | ? USD |
| 2018Q1 | -8.8 million USD | ? USD |
| 2017Q4 | -10.9 million USD | ? USD |
| 2017Q3 | -9.2 million USD | ? USD |
| 2017Q2 | -11.1 million USD | ? USD |
| 2017Q1 | -11.2 million USD | ? USD |
| 2016Q4 | -12.8 million USD | ? USD |
| 2016Q3 | -11.4 million USD | ? USD |
| 2016Q2 | -13.2 million USD | ? USD |
| 2016Q1 | -9.7 million USD | ? USD |
| 2015Q4 | -4.7 million USD | ? USD |
| 2015Q3 | -6.4 million USD | ? USD |
| 2015Q2 | -16.5 million USD | ? USD |
| 2015Q1 | -16.7 million USD | ? USD |
| 2014Q4 | -11.3 million USD | ? USD |
| 2014Q3 | -8.4 million USD | ? USD |
| 2014Q2 | -7.0 million USD | ? USD |
| 2014Q1 | -7.2 million USD | ? USD |
| 2013Q4 | -6.2 million USD | ? USD |
| 2013Q3 | -5.5 million USD | ? USD |
| 2013Q2 | -4.9 million USD | ? USD |
| 2013Q1 | -3.5 million USD | ? USD |
| 2012Q4 | -3.8 million USD | ? USD |
| 2012Q3 | -2.6 million USD | ? USD |
EIGR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -86.6 million USD | 14.7 million USD |
| 2022 | -96.8 million USD | 13.5 million USD |
| 2021 | -33.9 million USD | 12.1 million USD |
| 2020 | -68.6 million USD | 5.7 million USD |
| 2019 | -73.6 million USD | ? USD |
| 2018 | -52.4 million USD | ? USD |
| 2017 | -42.4 million USD | ? USD |
| 2016 | -47.1 million USD | ? USD |
| 2015 | -44.4 million USD | ? USD |
| 2014 | -33.9 million USD | ? USD |
| 2013 | -20.0 million USD | ? USD |
| 2012 | -15.7 million USD | ? USD |
| 2010 | -7.0 million USD | ? USD |
EIGR
Price: $1.72
52 week price:
Earnings Per Share: -58.50 USD
P/E Ratio: -0.10
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 759300
Ebitda: -8.8 millionMarket Capitalization: 2.6 million